Recent Updates
Recently added Catalysts

Endoscopic Radial Artery Harvest

Phase 2

Coronary Artery Disease | Unknown | Cardiovascular |Johnson & Johnson|Last Updated: Feb 17, 2020

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedUNCONTROLLED
Total Trials1
Total Enrollment119
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00303706Study of Endoscopic Versus Open Harvest of the Radial Artery in Coronary Artery Bypass SurgeryPHASE2 COMPLETED 119Apr 1, 2005Aug 1, 2007Feb 17, 20201 Canada
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
The primary outcome event will be the rate of forearm wound infection at 6 weeks.
6 weeks
Secondary Endpoints
Wound pain
6 weeks
Neurological complications
6 weeks
Patient satisfaction
6 weeks
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Interventions
NameTypeDescription
Endoscopic Radial Artery HarvestPROCEDURE -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 80 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Eligible patients greater than 18 years of age with coronary artery disease requiring elective, urgent, or emergency coronary artery revascularization where the radial artery can be used as a bypass conduit. Exclusion Criteria: * Patient's refusal to have surgery, inability ...

Countries:Canada
Unlock Eligibility Criteria